4.7 Review

Depression, Antidepressants, and Neurogenesis: A Critical Reappraisal

期刊

NEUROPSYCHOPHARMACOLOGY
卷 36, 期 13, 页码 2589-2602

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/npp.2011.220

关键词

neurogenesis; dentate gyrus; neurotrophic factors; stress; depression; antidepressant

资金

  1. NIH
  2. Eli Lilly
  3. Lundbeck A/S
  4. Cyberonics
  5. Ortho-McNeil Janssen
  6. AstraZeneca
  7. Dainippon Sumitomo Pharma
  8. SK Life Sciences
  9. Sunovion Pharmaceuticals
  10. Agency for Healthcare Research and Quality (AHRQ)
  11. CeNeRx BioPharma
  12. PharmaNeuroBoost

向作者/读者索取更多资源

The neurogenesis hypothesis of depression posits (1) that neurogenesis in the subgranular zone of the dentate gyrus is regulated negatively by stressful experiences and positively by treatment with antidepressant drugs and (2) that alterations in the rate of neurogenesis play a fundamental role in the pathology and treatment of major depression. This hypothesis is supported by important experimental observations, but is challenged by equally compelling contradictory reports. This review summarizes the phenomenon of adult hippocampal neurogenesis, the initial and continued evidence leading to the development of the neurogenesis hypothesis of depression, and the recent studies that have disputed and/or qualified those findings, to conclude that it can be affected by stress and antidepressants under certain conditions, but that these effects do not appear in all cases of psychological stress, depression, and antidepressant treatment. Neuropsychopharmacology (2011) 36, 2589-2602; doi:10.1038/npp.2011.220; published online 21 September 2011

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据